Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
+129K
-
Total reported value, excl. options
-
$623M
-
Value change
-
+$1.14M
-
Put/Call ratio
-
0.7
-
Number of buys
-
57
-
Number of sells
-
-52
-
Price
-
$33.18
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q2 2021
143 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q2 2021.
TransMedics Group, Inc. - Common Stock (TMDX) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 33.9M outstanding shares and own 55.33% of the company stock.
Largest 10 shareholders include FMR LLC (4.14M shares), BlackRock Inc. (1.83M shares), MACQUARIE GROUP LTD (1.52M shares), CREDIT SUISSE AG/ (1.51M shares), Sandhill Capital Partners LLC (1.43M shares), VANGUARD GROUP INC (1.23M shares), KPCB XIII Associates, LLC (923K shares), STATE STREET CORP (820K shares), Bellevue Group AG (730K shares), and GEODE CAPITAL MANAGEMENT, LLC (422K shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.